Company news
Kangmei Pharmaceutical Co., Ltd Class A (SSE:600518) news
Kangmei Pharmaceutical Co., Ltd Class A news releases on 6ix. Latest, Sep 8, 2026: "Kangmei Pharmaceutical Co., Ltd."Announcement on Resolutions of the 6th…
Press releases & updates
"Kangmei Pharmaceutical Co., Ltd."Announcement on Resolutions of the 6th Extraordinary Meeting of the 10th Board of Directors in 2026
September 7, 2026
"Kangmei Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
September 3, 2026
"Kangmei Pharmaceutical Co., Ltd."Announcement on Progress of Litigation Involved (II)
August 25, 2026
"Kangmei Pharmaceutical Co., Ltd."Notice on Convening the 2nd Extraordinary General Meeting in 2026
August 21, 2026
"Kangmei Pharmaceutical Co., Ltd."Announcement on Progress in Litigation Involved
July 20, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
June 12, 2026
Announcement on Changing Business Scope and Amending the Articles of Association
May 26, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 14, 2026
Report for Q1 2026
April 29, 2026
Announcement on Resignation of Director
April 20, 2026
Announcement on Not Planning Profit Distribution for 2025
April 17, 2026
Announcement on Transfer of Equity and Related Assets of the Wholly-owned Subsidiary
March 31, 2026
Announcement on Supplementary Payment of Taxes by the Wholly-owned Subsidiary
March 20, 2026
Announcement on Change of Signatory Certified Public Accountant and Project Quality Control Review Partner
January 9, 2026
Announcement on By-election of Members of Special Committees of the Board of Directors
January 5, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
December 26, 2025
Notice on Convening the 2nd Extraordinary General Meeting in 2025
December 10, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 13, 2025
Report for Q3 2025
October 30, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
October 9, 2025
Announcement on Receipt of Compensation Payment
September 30, 2025
2025 Semi-annual Report
August 29, 2025
Announcement on Result of the Application for Bankruptcy Liquidation of the Wholly-owned Subsidiary
August 18, 2025
Announcement on Resolutions of the 3rd Extraordinary Meeting of the 10th Board of Directors in 2025
July 17, 2025
Announcement on the Passive Formation of a Related Party Transaction Due to a Related Party's Acquisition of the Company's Creditor's Rights
July 4, 2025
Announcement on Progress of Litigation Enforcement by Subsidiaries (V)
June 13, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 15, 2025
Announcement on Resolutions of the 2024 Annual General Meeting
May 12, 2025
Announcement on Listing and Circulation of Partial Restricted Shares in Non-public Offering (II)
April 29, 2025
2024 Annual Report
April 18, 2025
Announcement on Resolution of the 1st Extraordinary Meeting of the 10th Board of Directors in 2025
February 17, 2025
Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
February 10, 2025
Announcement on Resolutions of the 1st Extraordinary Meeting of the 9th Board of Supervisors in 2025
January 23, 2025
Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
November 15, 2024
Announcement on Risk Warning in Stock Trading
November 11, 2024
Announcement on Abnormal Fluctuations in Stock Trading
November 8, 2024
Announcement on Convening the Q3 2024 Performance Briefing
November 7, 2024
Announcement on Resolutions of the 3rd Extraordinary Meeting of the 9th Board of Supervisors in 2024
October 30, 2024
Announcement on Progress of Litigation Enforcement by Subsidiaries (III)
October 8, 2024
Announcement on Convening the 2024 Semi-annual Performance Briefing
September 5, 2024
Announcement on Resolution of the 6th Meeting of 9th Board of Supervisors
August 23, 2024
Announcement on Progress of Litigation Enforcement by Subsidiaries (II)
August 19, 2024
Announcement on Progress of Litigation Enforcement by Subsidiaries
August 6, 2024
Announcement on Expected Gains in Semi-annual Performance for 2024
July 12, 2024
Announcement on the Removal of Other Risk Warnings for the Stock and Suspension of Trading
July 2, 2024
Announcement on Resolutions of 3rd Special Session of 9th Board of Directors of 2024
June 26, 2024
Announcement on Reply to "Letter of Supervision on Information Disclosure of 2023 Annual Report of Kangmei Pharmaceutical Co.,Ltd" from SSE
May 27, 2024
Announcement on Receiving Enforcement Decree from Court
May 17, 2024
Announcement on Convening Performance Meeting for 2023 and 1st Quarter of 2024
May 9, 2024
Announcement on Resolutions of 2023 Annual General Meeting
May 8, 2024